Recent News

• 05.13.2025 - HeartBeam Reports First Quarter 2025 Results
• 05.06.2025 - HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
• 05.05.2025 - HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
• 05.01.2025 - HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
• 04.29.2025 - HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
• 04.24.2025 - HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation
• 03.13.2025 - HeartBeam Reports Fourth Quarter and Full Year 2024 Results
• 03.06.2025 - HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
• 02.27.2025 - HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Recent Filings

• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.05.2025 - EX-99.1 EX-99.1
• 05.05.2025 - 8-K Current report
• 05.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.25.2025 - 8-K Current report
• 03.13.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2025 - 8-K Current report